EFDID: 404679EFD: View Filing

Issuer: Trevi Therapeutics, Inc. (0001563880) - D

Accession: 0001563880-21-000003 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001563880
  • Entity Name:
    Trevi Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    195 CHURCH STREET
    14TH FLOOR
    NEW HAVEN, CT 06510
  • Persons:
    Related Persons 10
    Jennifer L. Good
    Executive Officer, Director
    David Meeker
    Director
    James Cassella
    Director
    Edward Mathers
    Director
    Michael Heffernan
    Director
    Dominick Colangelo
    Director
    Anne VanLent
    Director
    Thomas Sciascia
    Executive Officer
    Lisa Delfini
    Executive Officer
    William Forbes
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    10/21/2021
  • First Sale Date:
    10/18/2021
  • Offering Amount:
    $3,000,000
  • Amount Sold:
    $3,000,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Trevi Therapeutics, Inc./s/ Jennifer L. GoodJennifer L. GoodPresident and Chief Executive Officer2021-10-21